7-5987144-T-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000535.7(PMS2):ā€‹c.1621A>Gā€‹(p.Lys541Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.85 in 1,611,014 control chromosomes in the GnomAD database, including 584,176 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K541R) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.87 ( 57167 hom., cov: 32)
Exomes š‘“: 0.85 ( 527009 hom. )

Consequence

PMS2
NM_000535.7 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15O:1

Conservation

PhyloP100: 1.50
Variant links:
Genes affected
PMS2 (HGNC:9122): (PMS1 homolog 2, mismatch repair system component) The protein encoded by this gene is a key component of the mismatch repair system that functions to correct DNA mismatches and small insertions and deletions that can occur during DNA replication and homologous recombination. This protein forms heterodimers with the gene product of the mutL homolog 1 (MLH1) gene to form the MutL-alpha heterodimer. The MutL-alpha heterodimer possesses an endonucleolytic activity that is activated following recognition of mismatches and insertion/deletion loops by the MutS-alpha and MutS-beta heterodimers, and is necessary for removal of the mismatched DNA. There is a DQHA(X)2E(X)4E motif found at the C-terminus of the protein encoded by this gene that forms part of the active site of the nuclease. Mutations in this gene have been associated with hereditary nonpolyposis colorectal cancer (HNPCC; also known as Lynch syndrome) and Turcot syndrome. [provided by RefSeq, Apr 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.4039015E-6).
BP6
Variant 7-5987144-T-C is Benign according to our data. Variant chr7-5987144-T-C is described in ClinVar as [Benign]. Clinvar id is 135065.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987144-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.917 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PMS2NM_000535.7 linkuse as main transcriptc.1621A>G p.Lys541Glu missense_variant 11/15 ENST00000265849.12

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PMS2ENST00000265849.12 linkuse as main transcriptc.1621A>G p.Lys541Glu missense_variant 11/151 NM_000535.7 P3P54278-1

Frequencies

GnomAD3 genomes
AF:
0.865
AC:
131537
AN:
151998
Hom.:
57124
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.925
Gnomad AMI
AF:
0.938
Gnomad AMR
AF:
0.772
Gnomad ASJ
AF:
0.893
Gnomad EAS
AF:
0.915
Gnomad SAS
AF:
0.895
Gnomad FIN
AF:
0.843
Gnomad MID
AF:
0.899
Gnomad NFE
AF:
0.845
Gnomad OTH
AF:
0.855
GnomAD3 exomes
AF:
0.841
AC:
210907
AN:
250846
Hom.:
89510
AF XY:
0.848
AC XY:
115081
AN XY:
135714
show subpopulations
Gnomad AFR exome
AF:
0.925
Gnomad AMR exome
AF:
0.669
Gnomad ASJ exome
AF:
0.889
Gnomad EAS exome
AF:
0.921
Gnomad SAS exome
AF:
0.895
Gnomad FIN exome
AF:
0.839
Gnomad NFE exome
AF:
0.850
Gnomad OTH exome
AF:
0.840
GnomAD4 exome
AF:
0.849
AC:
1238139
AN:
1458898
Hom.:
527009
Cov.:
51
AF XY:
0.851
AC XY:
617868
AN XY:
725902
show subpopulations
Gnomad4 AFR exome
AF:
0.930
Gnomad4 AMR exome
AF:
0.681
Gnomad4 ASJ exome
AF:
0.887
Gnomad4 EAS exome
AF:
0.930
Gnomad4 SAS exome
AF:
0.893
Gnomad4 FIN exome
AF:
0.842
Gnomad4 NFE exome
AF:
0.845
Gnomad4 OTH exome
AF:
0.861
GnomAD4 genome
AF:
0.865
AC:
131629
AN:
152116
Hom.:
57167
Cov.:
32
AF XY:
0.864
AC XY:
64262
AN XY:
74342
show subpopulations
Gnomad4 AFR
AF:
0.925
Gnomad4 AMR
AF:
0.771
Gnomad4 ASJ
AF:
0.893
Gnomad4 EAS
AF:
0.914
Gnomad4 SAS
AF:
0.895
Gnomad4 FIN
AF:
0.843
Gnomad4 NFE
AF:
0.845
Gnomad4 OTH
AF:
0.857
Alfa
AF:
0.854
Hom.:
73695
Bravo
AF:
0.859
TwinsUK
AF:
0.847
AC:
3141
ALSPAC
AF:
0.834
AC:
3216
ESP6500AA
AF:
0.918
AC:
4045
ESP6500EA
AF:
0.846
AC:
7270
ExAC
AF:
0.851
AC:
103334
Asia WGS
AF:
0.891
AC:
3101
AN:
3478
EpiCase
AF:
0.851
EpiControl
AF:
0.850

ClinVar

Significance: Benign
Submissions summary: Benign:15Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:9Other:1
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
not provided, no classification providedreference populationITMISep 19, 2013- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 05, 2018- -
Benign, no assertion criteria providedclinical testingClinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute-- -
Benign, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesOct 11, 2016- -
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo Clinic-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 28, 2016Disclaimer: This variant has not undergone full assessment. The following are pr eliminary notes: Frequency -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Lynch syndrome 4 Benign:3
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
Benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Benign, criteria provided, single submitterclinical testingIntelligeneCGAug 18, 2017- -
Mismatch repair cancer syndrome 4 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -
Lynch syndrome Benign:1
Benign, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthFeb 05, 2024- -
Hereditary nonpolyposis colorectal neoplasms Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.057
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
5.5
DANN
Benign
0.22
DEOGEN2
Benign
0.052
T;.;.;.;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.00058
N
LIST_S2
Benign
0.22
T;T;.;T;.
MetaRNN
Benign
0.0000014
T;T;T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-1.9
N;.;.;.;.
MutationTaster
Benign
1.0
P;P;P;P;P
PrimateAI
Benign
0.25
T
PROVEAN
Benign
0.76
N;N;.;.;.
REVEL
Benign
0.16
Sift
Benign
1.0
T;T;.;.;.
Sift4G
Benign
1.0
T;T;.;.;.
Polyphen
0.0
B;B;.;.;B
Vest4
0.049
MPC
0.045
ClinPred
0.0016
T
GERP RS
4.7
Varity_R
0.044
gMVP
0.15

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2228006; hg19: chr7-6026775; COSMIC: COSV56223170; API